Tameside General Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2003
NCT00902616
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now